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Reports about acquired resistance to colistin in diﬀerent bacteria species are increasing, including E. coli of animal origin, but
reports of resistance in wild S. enterica of diﬀerent serotypes from swine are not found in the literature. Results obtained with one
hundred and twenty-six E. coli strains from diseased swine and one hundred and twenty-four S. enterica strains from diseased and
carrier swine showed a frequency of 6.3% and 21% of colistin-resistant strains, respectively. When comparing the disk diﬀusion
test with the agar dilution test to evaluate the strains, it was confirmed that the disk diﬀusion test is not recommended to evaluate
colistin resistance as described previously. The colistin MIC 90 and MIC 50 values obtained to E. coli were 0.25 µg/mL and
0.5 µg/mL, the MIC 90 and MIC 50 to S. enterica were 1 µg/mL and 8 µg/mL. Considering the importance of colistin in control of
nosocomial human infections with Gram-negative multiresistant bacteria, and the large use of this drug in animal production, the
colistin resistance prevalence in enterobacteriaceae of animal origin must be monitored more closely.
1. Introduction
Polymyxyns are a group of polypeptide antibiotics positively
charged that derive from various species of Paenibacil-
lus (Bacillus) polymyxa. Out of five polimixyns originally
described, two have been used in the clinical setting,
polimixyn B and polymyxyn E, also known as colistin [1].
Colistin was discovered in 1949 and was later cau-
tiously used clinically because of reported high incidence of
nephrotoxicity and neurotoxicity. There are two forms of
colistin commercially available: colistin sulfate for oral and
topical use and colistimethate sodium for parenteral use;
both can be delivered by inhalation, but colistin sulfate, and
not colistimethate sodium, should be used for susceptibility
testing [2, 3].
Human Infections caused by multiresistant Gram-
negative bacteria such as Pseudomonas aeruginosa, Acineto-
bacter baumannii and Klebsiella pneumoniae are increasing
worldwide. In these cases, colistin has been attracting great
interest because of its significant activity against these agents
and low resistance rates to it [2].
In veterinary medicine, colistin sulfate is mainly used
in oral preparations, due to its excellent activity against
Escherichia coli and Salmonella enterica, low frequency of
resistance, and poor absorption after oral administration,
especially in pigs and poultry production, although in the
last few years the E. coli resistant to colistin is becoming more
common [4]. Mechanisms of acquired colistin resistance
have been described in diﬀerent Gram-negative bacteria,
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and, more extensively, in A. baumannii and Salmonella
Typhimurium [1, 5].
The disk diﬀusion test that is largely used in veterinary
laboratories does not seem to be a reliable method for detec-
tion of colistin resistance. A previous study [4] describes the
use of a disk prediﬀusion method as a rapid test to determine
susceptibility of pig E. coli isolates in Belgium, but occurrence
of colistin resistance in Salmonella enterica strains from swine
have not been described yet. In Brazil, there are no reports of
colistin resistance in E. coli and Salmonella enterica of animal
origin. The objective of this study is to evaluate colistin
resistance in E. coli and Salmonella enterica isolated from pigs
from commercial swine herds in Brazil.
2. Material andMethods
2.1. Collecting and Isolating Strains. One hundred and
twenty-six E. coli strains isolated from pigs presenting either
postweaning diarrhea or oedema disease were selected from
ten diﬀerent Brazilian swine herds. One hundred and twenty-
four Salmonella enterica subspecies enterica strains were
isolated from pigs presenting enterocolitis (45/124) from
nine swine herds. Carcasses, feces, and lymph nodes of
healthy pigs were examined at four Brazilian slaughterhouses
representing eight diﬀerent swine herds (79/124). There was
no correlation between the properties or animals where the
strains of E. coli and Salmonella enterica were isolated.
For E. coli isolation, feces and gut samples were inoc-
ulated on Columbia agar (Difco-BBL, Detroit, MIUSA)
supplemented with 5% sheep blood and MacConkey Agar
(Difco-BBL, Detroit, MI/USA), incubated for 24 h at 37◦C.
S. enterica isolation protocol consisted in inoculation
of feces, mesenteric lymph nodes, and carcass swabs into
100mL of tetrathionate broth (Difco-BBL, Detroit, MI/USA)
and incubation at 37◦C for 48 h, subculturing 10 µL of the
tetrathionate broth into 10mL Rappaport Vassiliadis (RV)
broth (Difco-BBL, Detroit, MI/USA) and incubation at 37◦C
for 24 h, then inoculating xylose-lysine-tergitol-4 (XLT4)
agar plates with 10 µL of the RV broth, and incubation for
24 h at 37◦C [6]. The isolates were identified as E. coli or
S. enterica by colony morphology and standard biochemical
methods [7].
2.2. Characterization of Strains. Isolates identified as E. coli
were characterized using polymerase chain reaction (PCR)
as previously described [8]. For this study one hundred and
twenty-six ETEC strains positive to one or more virulence
genes related to postweaning diarrhea or oedema disease as
F18 and F4 fimbria and heat-labile LT, heat-stable STa, and
Stx2e toxins were selected (data not shown).
Isolates identified as S. enterica through biochemical tests
were submitted to serotyping with antigenic characterization
based on the Kauﬀmann-White [9] at Fundac¸a˜o Instituto
Oswaldo Cruz (Fiocruz, Rio de Janeiro).
2.3. Colistin Susceptibility Tests. Antimicrobial sensitivity
testing was carried out using two diﬀerent techniques: the
agar dilution method [10] and the Kirby Bauer disk diﬀusion
test (Oxoid Ltd., Cambridge/UK). Colistin sulfate powder
was obtained from Sigma Chemical (St. Louis, Mo/EUA.)
and all tests were performed in Mueller Hinton agar (Difco-
BBL, Detroit, MI/USA).
The minimum inhibitory concentration (MIC) was
determined as the lowest concentration that inhibited visible
growth. The strains were considered to have acquired
resistance when their MIC was higher than the wild type cut-
oﬀ value (MIC > 2µg/mL) [4].
The disk diﬀusion test was performed with tablets of
10 µg (Oxoid Ltd., Cambridge/UK) according to the CLSI
guidelines [10]. Growth inhibition zone diameters weremea-
sured manually. Interpretative criteria to determine clinical
resistance were based upon breakpoints described previously
[11]-resistant ≤ 11mm and susceptible ≥ 14mm. E. coli
ATCC 25922 and S. Typhimurium ATCC 14024 were used
as control strains in all performed tests [12].
3. Results
3.1. Escherichia coli Strains. Using the agar dilution method,
eight E. coli strains (6.3%) were considered resistant to
colistin (Table 1). MIC 50 and MIC 90 values observed were
0.25 µg/mL and 0.5 µg/mL, respectively. When evaluating the
disk diﬀusion test results (Table 2), four strains classified as
resistant (3.2%), 37 with intermediate susceptibility (29.4%)
and 85 susceptible strains (67.4%) were observed.
3.2. Salmonella enterica Strains. From 124 S. enterica strains,
81 were classified as serotype Typhimurium, 13 as serotype
London, 11 as serotype Anatum, eight classified as S.
enterica subspecies enterica (O:4,5:-:1,2), seven as serotype
Choleraesuis, three as serotype Infantis and one as serotype
Bredeney. The distribution of resistant strains according to
serotype is presented in Table 3. Using agar dilution method
26 (21%) S. enterica strains were considered resistant to
colistin (Table 1). Observed MIC 50 and MIC 90 values
were 1 µg/mL and 8 µg/mL, respectively. When analyzing
disk diﬀusion test results (Table 2), five strains classified as
resistant (4%), 29 with intermediate susceptibility (23.4%),
and 90 susceptible strains (72.6%) were observed.
4. Discussion
The results obtained in this study confirm that the disk
diﬀusion method is not the recommended test to monitor
colistin resistance, since only 50% of E. coli and 20% of S.
enterica colistin resistant strains were detected using this test.
Poor results using the disk diﬀusionmethod to detect colistin
resistance had been previously described [4].
Using the agar dilution test, which is considered the gold
standard for colistin evaluation, 6.3% of E. coli and 21% of
S. enterica tested strains resistant to colistin were detected.
The frequency of E. coli resistant strains is similar to those
described by Boyen et al. [4], who report 9.6% (15/157), and
have also been reported before in E. coli of animal origin [13,
14].
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Table 1: Distribution of MIC values of swine E. coli and S. enterica strains through agar dilution test against colistin.
Agar dilution
Number of strains with colistin MIC values (µg/mL)
≤0.125 0.25 0.5 1 2 4 8 16 32 64 128 256
E. coli 23 51 40 4 0 [0 2 4 2 0 0 0]
S. enterica 0 1 59 30 8 [13 13 0 0 0 0 0]
The values inside [] represent resistant strains.
Table 2: Distribution of inhibition zone diameters swine E. coli and S. enterica strains through disk diﬀusion test against colistin.
Disk difusion
Number of strains with colistin inhibition zone values (mm)
8 9 10 11 12 13 14 15 16 17 18 19
E. coli [0 0 4 0] 34 3 74 2 8 0 1 0
S. enterica [0 0 5 0] 17 12 69 4 12 0 5 0
The values inside [] represent resistant strains.
Table 3: Distribution of colistin resistant strains among diﬀerent
Salmonella enterica serotypes isolated from swine.
Serotype
Strains Number of resistant strains
No (%) Agar dilution
test
Disk diﬀusion
test
S. Typhimurium 81 (65.3) 12 2
S. London 13 (10.5) 6 0
S. Anatum 11 (8.9) 3 0
S. enterica subsp.
enterica
(O:4,5:-:1,2)
8 (6.5) 4 3
S. Choleraesuis 7 (5.6) 0 0
S. Infantis 3 (2.4) 0 0
S. Bredeney 1 (0.8) 1 0
Total 124 26 5
Boyen et al. [4] described that the published MIC
values for human use do not predict clinical eﬃciency of
colistin when used in animal oral formulations. Following
values calculated by Burch [15], for a feed concentration of
66 ppm of colistin, the antimicrobial will reach bactericidal
concentration in the porcine jejunum for strains with a MIC
of 8 µg/mL, but not for strains with anMIC of 16 µg/mL. The
MIC values observed in this study in E. coli resistant strains
were 8 µg/mL (2 strains), 16 µg/mL (4 strains), and 32 µg/mL
(2 strains).
Salmonella Typhimurium resistance to colistin was
described by Sun et al. [3], who assessed spontaneous
mutations in PmrA and PmrB genes in S. Typhimurium
LT2 that present reduced susceptibility to colistin. They
report that the mutation rate to colistin resistance was 0.6 ×
106 per cell generation, which was considered several times
higher than mutations rates to other antibiotics, such as
streptomycin, rifampicin, and nalidixic acid. TheMIC values
observed in these mutants (2.5 µg/mL to 4 µg/mL) increased
20 to 30 times comparing to susceptible strain (0,125 µg/mL).
Reports of colistin resistance frequency in wild S. enterica
strains of animal origin and reports of resistance detection in
other serotypes diﬀerent from Typhimurium were not found
in the literature.
The MIC values identified in S. enterica resistant strains
(4 µg/mL and 8 µg/mL) were lower than those observed
in E. coli, but are still above the considered breakpoint
and are 32 to 64 times higher than MIC observed in S.
Typhimurium ATCC 14024 (0,125 µg/mL). In this study
colistin resistance was detected in wild Salmonella strains
from serotype Typhimurium, London, Anatum, Bredeney
and S. enterica subsp. enterica (O:4,5:-:1,2), suggesting that
the large use of colistin in swine herds from Brazil is
selecting resistant strains independent of serotype. Part of
these Salmonella resistant strains was isolated from carcasses,
lymph nodes and feces of pigs at slaughterhouses.
Humans may obtain antimicrobial resistant bacteriaor
resistance genes of animal origin directly via contact with
animals, food of animal origin, or the environment. These
bacteria may subsequently colonize humans or may transfer
resistance genes to other bacteria during passage through the
intestinal tract. The contribution of the animal reservoir to
the burden of antimicrobial resistance in humans has not
been quantified; however, the use of antimicrobial agents
regarded as critically or highly important for use in humans
should be avoided or minimized in food animals [16].
Considering the high use of colistin in animal production
and the importance of this antimicrobial for the control
of multiresistant Gramnegative nosocomial infections in
humans, more intensive studies must be conducted to
monitor the resistance in animal isolates and resistance
mechanisms involved.
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